Literature DB >> 1773288

Para-urethral collagen implantation for female stress incontinence.

S D Eckford1, P Abrams.   

Abstract

A series of 25 women with genuine stress incontinence were treated by para-urethral injection of glutaraldehyde cross-linked collagen. The technique was simple and associated with few complications. Follow-up at 3 months revealed 20 patients (80%) to have been symptomatically improved or cured. An increase in urethral closure pressure together with a decrease in urine flow rate and increase in detrusor pressure was found post-operatively. The success rate was significantly higher (90%) in patients who had undergone previous surgery for urinary incontinence when compared with those who had had no previous surgery (73%).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773288     DOI: 10.1111/j.1464-410x.1991.tb15420.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

Review 2.  Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result.

Authors:  E J McGuire; S F English
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).

Authors:  Farah Lone; Abdul H Sultan; Ranee Thakar
Journal:  Int Urogynecol J       Date:  2010-06-23       Impact factor: 2.894

4.  Collagen injections for genuine stress urinary incontinence: patient selection and durability.

Authors:  S Herschorn; S B Radomski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 5.  Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.